The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2294-2299

  Grarup, Niels ^a   Andreasen, Camilla H ^a   Andersen, Mette K ^a,b   Albrechtsen, Anders ^c   Sandbæk, Annelli ^d   Lauritzen, Torsten ^d   Borch Johnsen, Knut ^a,e,f   Jørgensen, Torben ^f   Schmitz, Ole ^d,g   Hansen, Torben ^a   Pedersen, Oluf ^a,e  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; ENVIRONMENTAL FACTOR; FEMALE; GENOTYPE; GLUCOSE TOLERANCE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SELF REPORT;

EID: 45149095026     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2815     Document Type: Article

References (36)

1. Thuren T 2000 Hepatic lipase and HDL metabolism. Curr Opin Lipidol 11:277-283
2. Lambert G, Chase MB, Dugi K, Bensadoun A, Brewer HB, Santamarina-Fojo S 1999 Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J Lipid Res 40:1294-1303
3. Barbagallo CM, Fan J, Blanche PJ, Rizzo M, Taylor JM, Krauss RM 1999 Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Arterioscler Thromb Vasc Biol 19:625-632
4. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD 2003 Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 14:179-189
5. Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, Taylor JM 1994 Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA 91:8724-8728
6. Dichek HL, Brecht W, Fan J, Ji ZS, McCormick SP, Akeefe H, Conzo L, Sanan DA, Weisgraber KH, Young SG, Taylor JM, Mahley RW 1998 Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J Biol Chem 273:1896-1903
7. Blades B, Vega GL, Grundy SM 1993 Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb 13:1227-1235
8. Andersen RV, Wittrup HH, Tybaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG 2003 Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease-the Copenhagen City Heart Study. J Am Coll Cardiol 41:1972-1982
9. Deeb SS, Peng R 2000 The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res 41:155-158
10. Tahvanainen E, Syvanne M, Frick MH, Murtomaki-Repo S, Antikainen M, Kesaniemi YA, Kauma H, Pasternak A, Taskinen MR, Ehnholm C 1998 Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators. J Clin Invest 101:956-960
11. Bos G, Snijder MB, Nijpels G, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, Jansen H 2005 Opposite contributions of trunk and leg fat mass with plasma lipase activities: the Hoorn study. Obes Res 13:1817-1823
12. Nie L, Wang J, Clark LT, Tang A, Vega GL, Grundy SM, Cohen JC 1998 Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 39:1127-1130
13. Peltonen P, Marniemi J, Hietanen E, Vuori I, Ehnholm C 1981 Changes in serum lipids, lipoproteins, and heparin releasable lipolytic enzymes during moderate physical training in man: a longitudinal study. Metabolism 30:518-526
14. Mendoza SG, Carrasco H, Zerpa A, Briceno Y, Rodriguez F, Speirs J, Glueck CJ 1991 Effect of physical training on lipids, lipoproteins, apolipoproteins, lipases, and endogenous sex hormones in men with premature myocardial infarction. Metabolism 40:368-377
15. Isaacs A, Sayed-Tabatabaei FA, Njajou OT, Witteman JC, van Duijn CM 2004 The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. J Clin Endocrinol Metab 89:3858-3863
16. Ordovas JM, Corella D, Demissie S, Cupples LA, Couture P, Coltell O, Wilson PW, Schaefer EJ, Tucker KL 2002 Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 106:2315-2321
17. St Pierre J, Miller-Felix I, Paradis ME, Bergeron J, Lamarche B, Després JP, Gaudet D, Vohl MC 2003 Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men. Mol Genet Metab 78:31-36
18. Todorova B, Kubaszek A, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M, Finnish Diabetes Prevention Study 2004 The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89:2019-2023
19. Zacharova J, Todorova BR, Chiasson JL, Laakso M, STOP-NIDDM Study Group 2005 The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: The STOP-NIDDM trial. J Intern Med 257:185-193
20. Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O'Rahilly S, Wareham NJ 2003 Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol [Erratum (2003) 1:445] 1:E20
21. Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C 2003 A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10:377-386
22. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G, Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care 2000 The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 24(Suppl 3):S6-S11
23. World Health Organization Study Group 1999 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Tech Rep Ser WHO/NCD/NCS/99.2 ed. Geneva: World Health Organization
24. Grarup N, Albrechtsen A, Ek J, Borch-Johnsen K, Jørgensen T, Schmitz O, Hansen T, Pedersen O 2007 Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people. Diabetologia 50:1201-1208
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
26. Saltin B, Grimby G 1968 Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages. Circulation 38:1104-1115
27. Toft U, Kristoffersen L, Ladelund S, Bysted A, Jakobsen J, Lau C, Jorgensen T, Borch-Johnsen K, Ovesen L 2007 Relative validity of a food frequency questionnaire used in the Inter99 study. Eur J Clin Nutr advance online publication 30 May 2007; doi: 10.1038/sj.ejcn. 1602815
28. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A 2001 High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 98:581-584
29. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA 1989 High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8-15
30. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB 1986 Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256:2835-2838
31. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W, Atherosclerosis Risk in Communities Study Group 2001 Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104:1108-1113
32. Dugi KA, Brandauer K, Schmidt N, Nau B, Schneider JG, Mentz S, Keiper T, Schaefer JR, Meissner C, Kather H, Bahner ML, Fiehn W, Kreuzer J 2001 Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation 104:3057-3062
33. Ansell BJ, Fonarow GC, Fogelman AM 2007 The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol 18:427-434
34. Roberts CK, Ng C, Hama S, Eliseo AJ, Barnard RJ 2006 Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. J Appl Physiol 101:1727-1732
35. Zhang C, Lopez-Ridaura R, Rimm EB, Rifai N, Hunter DJ, Hu FB 2005 Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men. Am J Clin Nutr 81:1429-1435
36. Grarup N, Andersen G 2007 Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism. Curr Opin Clin Nutr Metab Care 10:420-426